NeoGenomics Inc (NEO): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2019-12-31, 2020-12-31, 2021-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

128.15M

As of 2025-12-31

127.92M

As of 2026-06-30

+0.3%

3-year compound annual growth

2010-12-31 Shares Outstanding (shares) 2025-12-31

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	128.15M	0.0%	2026-02-17, Balance as of period end
2024-12-31	128.15M	+0.6%	2026-02-17, Balance as of period end
2023-12-31	127.37M	+0.4%	2025-02-18, Balance as of period end
2022-12-31	126.91M	n/c	2024-02-20, Balance as of period end
2021-12-31	124.11M	n/c	2023-02-24, Balance as of period end
2020-12-31	112.08M	n/c	2022-02-25, Balance as of period end
2019-12-31	104.78M	n/c	2021-02-25, Balance as of period end
2018-12-31	94.47M	+17.4%	2020-02-28, Balance as of period end
2017-12-31	80.46M	+2.4%	2019-02-26, Balance as of period end
2016-12-31	78.57M	+3.6%	2018-03-13, Balance as of period end
2015-12-31	75.82M	+25.9%	2017-03-14, Balance as of period end
2014-12-31	60.24M	+22.6%	2016-04-18, Balance as of period end
2013-12-31	49.12M	+8.5%	2015-03-03, Balance as of period end
2012-12-31	45.28M	+4.3%	2014-02-24, Balance as of period end
2011-12-31	43.42M	+16.0%	2013-02-21, Balance as of period end
2010-12-31	37.42M	n/a	2012-03-12, Balance as of period end